Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl-Johan Malmberg

Showing results (91-100 of 127) with videos related to

Pageof 13
Sort By:
Cytotherapy|December 3, 2020
Cellular immunotherapy with multiple infusions of in vitro-expanded haploidentical natural killer cells after autologous transplantation for patients with plasma cell myelomaAstrid Tschan-Plessl, Christian P Kalberer, Ronja Wieboldt, et al.
Blood Advances|March 14, 2024
A temporal developmental map separates human NK cells from noncytotoxic ILCs through clonal and single-cell analysisDang Nghiem Vo, Ouyang Yuan, Minoru Kanaya, et al.
Blood|October 26, 2021
Perturbed NK-cell homeostasis associated with disease severity in chronic neutropeniaEbba Sohlberg, Aline Pfefferle, Eivind Heggernes Ask, et al.
Journal for Immunotherapy of Cancer|January 26, 2022
PD-L1 CAR effector cells induce self-amplifying cytotoxic effects against target cellsMalgorzata Bajor, Agnieszka Graczyk-Jarzynka, Katsiaryna Marhelava, et al.
Acta Biomaterialia|November 11, 2024
Interleukin-12 decorated nanosized semiflexible Immunofilaments enable directed targeting and augmented IFNγ responses of natural killer cellsLea Weiss, Marjolein Schluck, René Classens, et al.
Genes and Immunity|November 2, 2024
The HLA-B -21 M/T dimorphism associates with disease severity in COVID-19Benedikt Strunz, Pouria Momayyezi, Eleni Bilev, et al.
Immunity|March 19, 2015
Cytomegalovirus infection drives adaptive epigenetic diversification of NK cells with altered signaling and effector functionHeinrich Schlums, Frank Cichocki, Bianca Tesi, et al.
Cancer Immunology Research|February 21, 2018
Intrinsic Functional Potential of NK-Cell Subsets Constrains Retargeting Driven by Chimeric Antigen ReceptorsVincent Yi Sheng Oei, Marta Siernicka, Agnieszka Graczyk-Jarzynka, et al.
Blood|January 18, 2013
NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRsVivien Béziat, Lisa L Liu, Jenny-Ann Malmberg, et al.
Med (New York, N.Y.)|May 19, 2022
A Systemic Protein Deviation Score Linked to PD-1<sup>+</sup> CD8<sup>+</sup> T Cell Expansion That Predicts Overall Survival in Diffuse Large B Cell LymphomaEivind Heggernes Ask, Astrid Tschan-Plessl, Thea Johanne Gjerdingen, et al.
Pageof 13

Showing results (91-100 of 127) with videos related to

Sort By:
Pageof 13
Cytotherapy|December 3, 2020
Cellular immunotherapy with multiple infusions of in vitro-expanded haploidentical natural killer cells after autologous transplantation for patients with plasma cell myelomaAstrid Tschan-Plessl, Christian P Kalberer, Ronja Wieboldt, et al.
Blood Advances|March 14, 2024
A temporal developmental map separates human NK cells from noncytotoxic ILCs through clonal and single-cell analysisDang Nghiem Vo, Ouyang Yuan, Minoru Kanaya, et al.
Blood|October 26, 2021
Perturbed NK-cell homeostasis associated with disease severity in chronic neutropeniaEbba Sohlberg, Aline Pfefferle, Eivind Heggernes Ask, et al.
Journal for Immunotherapy of Cancer|January 26, 2022
PD-L1 CAR effector cells induce self-amplifying cytotoxic effects against target cellsMalgorzata Bajor, Agnieszka Graczyk-Jarzynka, Katsiaryna Marhelava, et al.
Acta Biomaterialia|November 11, 2024
Interleukin-12 decorated nanosized semiflexible Immunofilaments enable directed targeting and augmented IFNγ responses of natural killer cellsLea Weiss, Marjolein Schluck, René Classens, et al.
Genes and Immunity|November 2, 2024
The HLA-B -21 M/T dimorphism associates with disease severity in COVID-19Benedikt Strunz, Pouria Momayyezi, Eleni Bilev, et al.
Immunity|March 19, 2015
Cytomegalovirus infection drives adaptive epigenetic diversification of NK cells with altered signaling and effector functionHeinrich Schlums, Frank Cichocki, Bianca Tesi, et al.
Cancer Immunology Research|February 21, 2018
Intrinsic Functional Potential of NK-Cell Subsets Constrains Retargeting Driven by Chimeric Antigen ReceptorsVincent Yi Sheng Oei, Marta Siernicka, Agnieszka Graczyk-Jarzynka, et al.
Blood|January 18, 2013
NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRsVivien Béziat, Lisa L Liu, Jenny-Ann Malmberg, et al.
Med (New York, N.Y.)|May 19, 2022
A Systemic Protein Deviation Score Linked to PD-1<sup>+</sup> CD8<sup>+</sup> T Cell Expansion That Predicts Overall Survival in Diffuse Large B Cell LymphomaEivind Heggernes Ask, Astrid Tschan-Plessl, Thea Johanne Gjerdingen, et al.
Pageof 13